MedTrace Logo

Impairment Oriented Versus Task Oriented Gait Training In Transfemoral Amputee Rehabilitation.

NCT07578051 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-11

No results posted yet for this study

Summary

This study examines the comparison between Impairment Oriented versus Task Oriented Gait Training in Transfemoral Amputee Rehabilitation. A randomized controlled trial conducted with 40 participants divided into two groups .Both groups receive pre-gait training and corrective walking exercises for 10 days .

Conditions

  • Transfemoral Amputees

Interventions

PROCEDURE

Impairment oriented (Group A)

Participants will receive ten days training programs with 5 days in each week. Each session will include warm up followed by sit to stand , stand to sit, walking in parallel bars ,ascend and descend stairs. Participants with group A will receive strengthening exercises of hip flexor , abductors, adductors and bridging of 10 repetition with 10-20 second hold according to patient.

PROCEDURE

Task oriented (Group B)

Participants will receive ten days training programs with 5 days in each week. Each session will include warm up followed by sit to stand , stand to sit, walking in parallel bars ,ascend and descend stairs. Participants with group B will receive lateral trunk bending, stepping over obstacle, lateral step ups, walk with visual markers on floor, sit to stand focus on glutes activation.

Sponsors & Collaborators

  • Foundation University Islamabad

    lead OTHER

Principal Investigators

  • Saliha Bibi, DPT · Foundation University Islamabad

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-06
Primary Completion
2026-07-01
Completion
2026-07-15

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07578051 on ClinicalTrials.gov